Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05725096

Role of Coronary CTA on Lipid Management and Risk Factors Control in an Asymptomatic Chinese Population

Role of the Screening with Coronary Computed Tomography Angiography on Lipid Management and Risk Factors Control in an Asymptomatic Chinese Population: a Community-based, Prospective Randomised Trial

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
3,400 (estimated)
Sponsor
Zhang longjiang,MD · Academic / Other
Sex
All
Age
40 Years – 69 Years
Healthy volunteers
Not accepted

Summary

The primary objective of this study is to determine whether coronary computed tomography angiography (CCTA) -based coronary heart disease(CHD) prevention strategy improves lipid-lowering treatment and cardiovascular risk factor control compared with traditional CHD prevention strategy, guided by a cardiovascular risk score.

Detailed description

At present, doctors usually use a "risk score" to identify people at risk of heart disease who may benefit from medical treatment. In the RESPECT study the investigator will compare this "risk score" to coronary CTA scan. In this study the investigator would like to determine the effect of coronary CTA scan on lipid-lowering treatment and cardiovascular risk factor control. This study will recruit 3400 eligible community volunteers (asymptomatic individuals free of any known cardiovascular event) aged 40 to 69 years, then, randomized (1:1) them to receive individualized primary prevention programs for coronary heart disease based on CCTA results or traditional risk score, as recommended in the Chinese CVD prevention guidelines. The intervention strategies in this study are consistent with RESPECT trial. The investigator will assess the difference of lipid-lowering treatment and cardiovascular risk factor control between two groups 12 months later. Furthermore, the investigator will present the results of subclinical coronary atherosclerosis in participants who have undergone coronary CTA scans. This will help us understand the prevalence of subclinical coronary atherosclerotic disease in an asymptomatic Chinese population.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTCoronary Computed Tomography AngiographyIntervention strategies according to CCTA results
OTHERTraditional cardiovascular risk stratificationIntervention strategies according to traditional cardiovascular risk stratification based on Chinese guidelines for lipid management (2023)

Timeline

Start date
2023-06-28
Primary completion
2025-03-01
Completion
2027-06-01
First posted
2023-02-13
Last updated
2024-11-26

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05725096. Inclusion in this directory is not an endorsement.